BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8937477)

  • 1. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.
    Ware JA; Svensson CK
    Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
    Walraven JM; Doll MA; Hein DW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes.
    Wang H; Wagner CR; Hanna PE
    Chem Res Toxicol; 2005 Feb; 18(2):183-97. PubMed ID: 15720122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids.
    Jones RF; Land SJ; King CM
    Carcinogenesis; 1996 Aug; 17(8):1729-33. PubMed ID: 8761433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.
    Stepp MW; Mamaliga G; Doll MA; States JC; Hein DW
    Biochem Biophys Rep; 2015 Sep; 3():45-50. PubMed ID: 26309907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Detection of multiple enzyme forms by mechanism-based inactivation.
    Wick MJ; Hanna PE
    Biochem Pharmacol; 1990 Mar; 39(6):991-1003. PubMed ID: 2322300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
    Tsirka T; Boukouvala S; Agianian B; Fakis G
    Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
    Goodfellow GH; Dupret JM; Grant DM
    Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
    Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
    Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
    Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
    Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene.
    Sticha KR; Bergstrom CP; Wagner CR; Hanna PE
    Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
    Wagner CR; Bergstrom CP; Koning KR; Hanna PE
    Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.
    Stepp MW; Doll MA; Samuelson DJ; Sanders MA; States JC; Hein DW
    BMC Cancer; 2017 Mar; 17(1):233. PubMed ID: 28359264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.